We are live on ! Find out more
LFMD icon

LifeMD

40 hedge funds and large institutions have $10.5M invested in LifeMD in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

28% more call options, than puts

Call options by funds: $220K | Put options by funds: $172K

0% more funds holding

Funds holding: 4040 (0)

0.65% less ownership

Funds ownership: 17.94%17.29% (-0.65%)

6% less capital invested

Capital invested by funds: $11.3M → $10.5M (-$732K)

40% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 15

Holders
40
Holders Change
Holders Change %
0%
% of All Funds
0.69%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
9
Reduced
15
Closed
3
Calls
$220K
Puts
$172K
Net Calls
+$48K
Net Calls Change
+$39K

LFMD Hedge Fund Activity: Q3 2022 in Review

40 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in LifeMD (LFMD) for Q3 2022, worth a combined $10.5M — down 6.5% from $11.3M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new LFMD positions and 3 closed out — a net gain of 2 holders — while 9 added to existing stakes and 15 trimmed.

The largest buyer was Royce & Associates, adding an estimated $620K. The largest seller was Granahan Investment Management, cutting an estimated $328K.

  • 40 institutional investors held LifeMD (LFMD) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $10.5M of LifeMD stock for Q3 2022, down 6.5% quarter-over-quarter.
  • 5 funds opened new LifeMD positions in Q3 2022 and 3 closed out, a net change of +2 holders.
  • The largest LifeMD buyer in Q3 2022 was Royce & Associates, an estimated $620K added.
  • The largest LifeMD seller in Q3 2022 was Granahan Investment Management, an estimated $328K sold.

Based on aggregated 13F filings for Q3 2022.